Subtype
Malignant Intestinal Neoplasm
CI-CAN-00001137Explore in graph →
1,666 active trials21 approved drugs383 evidence items
- NCIt
- C4572
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001137Explore in graph →
Clinical trials
7,771 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (772)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00006094 | Oxaliplatin, Fluorouracil, and External-Beam Radiation Therapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum | completed | Phase 1 / Phase 2 | 24 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00077259 | Epothilone D as Second-Line Treatment for Patients With Advanced or Metastatic Refractory Colorectal Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 16, 2013 |
| clinicaltrials |
| NCT01116271 | Study of Selumetinib (AZD6244)(ARRY-142886) in Combination With Irinotecan in Previously Treated Patients With Colorec | completed | Phase 2 | 32 | AstraZenecaINDUSTRY | 1 | Jan 14, 2013 | clinicaltrials |
| NCT00039273 | Monoclonal Antibody Therapy in Treating Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 44 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jan 8, 2013 | clinicaltrials |
| NCT00784446 | First-line Therapy of Stage IV Colorectal Cancer | completed | Phase 1 / Phase 2 | 51 | University of CologneOTHER | 1 | Jan 7, 2013 | clinicaltrials |
| NCT00049335 | S0030: Capecitabine in Treating Older Patients W/Metastatic or Recurrent Colorectal Cancer That Cannot Be Surgically Removed | completed | Phase 2 | 29 | SWOG Cancer Research NetworkNETWORK | 1 | Jan 3, 2013 | clinicaltrials |
| NCT00597506 | Expanded Cohort for Metastatic Colorectal Cancer (MCRC) Using Bevacizumab + Everolimus(BEV/EV) | completed | Phase 2 | 50 | Herbert HurwitzOTHER | 1 | Dec 27, 2012 | clinicaltrials |
| NCT00466505 | Cetuximab & Celecoxib for Metastatic Colorectal Cancer or Colorectal Cancer That Cannot Be Removed by Surgery | completed | Phase 2 | 17 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Dec 19, 2012 | clinicaltrials |
| NCT00557102 | Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver and/or Lung(ERBIFORT) | completed | Phase 2 | 24 | National Cancer Institute, FranceOTHER_GOV | 1 | Dec 11, 2012 | clinicaltrials |
| NCT01243047 | Intermittent Versus Continuous Tarceva Study | completed | Phase 2 | 60 | Chinese University of Hong KongOTHER | 1 | Nov 22, 2012 | clinicaltrials |
| NCT00284258 | Phase II/III Trial of CPT-11/5-FU/l-LV Versus CPT-11/TS-1 as Second Line Chemotherapy of Unresectable Colorectal Cancer | completed | Phase 2 / Phase 3 | 426 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Nov 2, 2012 | clinicaltrials |
| NCT00569335 | Phase II Trial of Combination Therapy With S-1, Irinotecan, and Bevacizumab (SIRB) in Patients With Unresectable or Recurrent Colorectal Cancer | completed | Phase 2 | 52 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Nov 2, 2012 | clinicaltrials |
| NCT00569699 | Phase II Trial of Combination Therapy With Bevacizumab and S-1 in Elderly Patients With Unresectable or Recurrent Colorectal Cancer (BASIC) | completed | Phase 2 | 56 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Nov 2, 2012 | clinicaltrials |
| NCT00569790 | Phase II Trial of Combination Therapy With Irinotecan, S-1, and Bevacizumab (IRIS/Bev) in Patients With Unresectable or Recurrent Colorectal Cancer | completed | Phase 2 | 53 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Nov 2, 2012 | clinicaltrials |
| NCT00721916 | Randomized Phase II Study of SOL for Untreated Metastatic Colorectal Cancer | completed | Phase 2 | 107 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Nov 1, 2012 | clinicaltrials |
| NCT00030524 | ZD 1839 in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer | completed | Phase 2 | — | The University of Texas Health Science Center at San AntonioOTHER | 1 | Oct 30, 2012 | clinicaltrials |
| NCT00278889 | Second Line ColoRectal Cancer Therapy in Combination With Combination of FOL- Folinic Acid(Leucovorin), F - Fluorouracil and OX - Oxaliplatin (FOLFOX)(HORIZON I) | completed | Phase 2 | 215 | AstraZenecaINDUSTRY | 9 | Oct 24, 2012 | clinicaltrials |
| NCT00003939 | Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma | completed | Phase 2 | 132 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 0 | Sep 24, 2012 | clinicaltrials |
| NCT00006357 | STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma | completed | Phase 1 / Phase 2 | 91 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Sep 24, 2012 | clinicaltrials |
| NCT00079261 | Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma | completed | Phase 2 | 25 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Sep 24, 2012 | clinicaltrials |
| NCT00607282 | Efficacy of Udenafil After Radical Resection for Sigmoid Colon and Rectal Cancer | completed | Phase 2 | 46 | Seoul National University HospitalOTHER | 1 | Sep 5, 2012 | clinicaltrials |
| NCT00113230 | Neoadjuvant Chemoradiation With RHUMAB VEGF (Avastin) for Rectal Cancer | completed | Phase 2 | 25 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 7, 2012 | clinicaltrials |
| NCT01269060 | Efficacy of Single Incision (Embryonic NOTES) Laparoscopic Colorectal Surgery | completed | Phase 2 | 48 | National Cancer Center, KoreaOTHER_GOV | 1 | Aug 6, 2012 | clinicaltrials |
| NCT00910676 | Study About Preventive Treatment of Folliculitis Induced by Epidermal Growth Factor Receptor Inhibitors(DIPROCOL) | completed | Phase 2 | 30 | Centre Oscar LambretOTHER | 1 | Jul 31, 2012 | clinicaltrials |
| NCT00862342 | Post-First Progression Use of Bevacizumab in Metastatic Colorectal Cancer (mCRC)(SAFE) | completed | Phase 2 | 78 | Asan Medical CenterOTHER | 1 | Jul 17, 2012 | clinicaltrials |
| NCT00039208 | Combination Chemotherapy in Treating Patients With Colorectal Cancer | completed | Phase 2 | — | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 4 | Jul 13, 2012 | clinicaltrials |
| NCT00529984 | A Phase I/II Study With CEA(6D) VRP Vaccine in Patients With Advanced or Metastatic CEA-Expressing Malignancies(CEA(6D)VRP) | completed | Phase 1 / Phase 2 | 28 | AlphaVax, Inc.INDUSTRY | 1 | Jul 12, 2012 | clinicaltrials |
| NCT00055822 | Combination Chemotherapy and Oblimersen in Treating Patients With Advanced Colorectal Cancer | completed | Phase 1 / Phase 2 | 16 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Jul 4, 2012 | clinicaltrials |
| NCT00005833 | S9923 R115777 in Treating Patients With Advanced Colorectal Cancer | completed | Phase 2 | 62 | SWOG Cancer Research NetworkNETWORK | 1 | Jun 14, 2012 | clinicaltrials |
| NCT00792363 | Irinotecan and Panitumumab as 3rd Line Treatment for mCRC Without KRAS Mutations | completed | Phase 2 | 32 | Vejle HospitalOTHER | 1 | Jun 13, 2012 | clinicaltrials |
| NCT00004895 | Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery | completed | Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00004910 | Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction | completed | Phase 1 / Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00004911 | Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction | completed | Phase 1 / Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00217711 | Oxaliplatin, Irinotecan, and Capecitabine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Cannot Be Removed By Surgery | completed | Phase 1 / Phase 2 | 23 | Swiss Cancer InstituteOTHER | 1 | Jun 5, 2012 | clinicaltrials |
| NCT00227734 | Capecitabine and Oxaliplatin With or Without Cetuximab in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery | completed | Phase 2 | 74 | Swiss Cancer InstituteOTHER | 1 | Jun 5, 2012 | clinicaltrials |
| NCT00080834 | DJ-927 as Second-Line Therapy in Treating Patients With Progressive Locally Advanced or Metastatic Colorectal Adenocarcinoma | completed | Phase 2 | — | Daiichi SankyoINDUSTRY | 1 | May 16, 2012 | clinicaltrials |
| NCT00030797 | Combination Chemotherapy in Treating Patients With Advanced or Metastatic Colorectal Cancer | completed | Phase 2 | 75 | Swiss Cancer InstituteOTHER | 1 | May 15, 2012 | clinicaltrials |
| NCT00089401 | Isolated Hepatic Perfusion With Melphalan in Treating Patients With Unresectable Colorectal Cancer That Has Metastasized to the Liver | completed | Phase 2 | 8 | National Institutes of Health Clinical Center (CC)NIH | 1 | May 14, 2012 | clinicaltrials |
| NCT00286130 | Safety and Efficacy of Folfox6 + Cetuximab Versus Folfiri +Cetuximab in Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 150 | Central European Cooperative Oncology GroupOTHER | 13 | May 1, 2012 | clinicaltrials |
| NCT01129700 | Short-course Preoperative Chemoradiotherapy Followed by Delayed Operation for Locally Advanced Rectal Cancer | completed | Phase 2 | 73 | National Cancer Center, KoreaOTHER_GOV | 1 | Apr 27, 2012 | clinicaltrials |
| NCT01574027 | Efficacy of Vitamin D in Colorectal Cancer Chemoprevention | completed | Phase 2 | 55 | University of Illinois at ChicagoOTHER | 1 | Apr 10, 2012 | clinicaltrials |
| NCT00019786 | Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases | completed | Phase 2 | 67 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 23, 2012 | clinicaltrials |
| NCT01387880 | Irinotecan, Cetuximab and Everolimus to Patients With Metastatic Colorectal Cancer(ICE) | completed | Phase 2 | 100 | Herlev HospitalOTHER | 1 | Mar 20, 2012 | clinicaltrials |
| NCT00003254 | SWOG-S9635 Fluorouracil Plus Ethynyluracil in Advanced Colorectal Cancer Not Responded to Fluorouracil | completed | Phase 2 | 75 | SWOG Cancer Research NetworkNETWORK | 1 | Mar 8, 2012 | clinicaltrials |
| NCT00786643 | Study of Gamma Interfereon in Metastatic Colorectal Carcinoma(GFL) | completed | Phase 2 | 48 | Accelerated Community Oncology Research NetworkOTHER | 1 | Mar 1, 2012 | clinicaltrials |
| NCT00137878 | TNFerade™ Plus Chemo/Radiation/Surgery for Rectal Cancer | completed | Phase 2 | — | GenVecINDUSTRY | 1 | Feb 23, 2012 | clinicaltrials |
| NCT00176774 | Irinotecan, 5-Fluorouracil, and Leucovorin in Colorectal Carcinoma | completed | Phase 2 | 24 | University of Michigan Rogel Cancer CenterOTHER | 1 | Feb 7, 2012 | clinicaltrials |
| NCT00313859 | Phase II Study of Simvastatin Plus Irinotecan, Fluorouracil, and Leucovorin(FOLFIRI) for Metastatic CRC | completed | Phase 2 | 50 | Samsung Medical CenterOTHER | 1 | Feb 2, 2012 | clinicaltrials |
| NCT00690677 | Phase II Trial of LBH589 in Refractory Colorectal Cancer | completed | Phase 2 | 29 | Swedish Medical CenterOTHER | 1 | Jan 18, 2012 | clinicaltrials |
| NCT00891332 | Study of S-1 Plus LV for Untreated Metastatic Colorectal Cancer | completed | Phase 2 | 73 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 2 | Jan 18, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Jan 16, 2013source: clinicaltrials